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Agatha Schwarz1
UVR suppresses the immune system in an antigen-specific manner via induction of regulatory T cells (Tregs). The
specific immunosuppression by UVR harbors therapeutic potential but is associated with UVR-induced DNA
damage, requiring the identification of other triggers inducing the same immunosuppressive effects without
DNA damage. The aryl hydrocarbon receptor (AhR) was identified as a molecular target for UVR and its activation
to be involved in UVR-induced immunosuppression. Accordingly, the AhR agonist 4-n-nonylphenol (NP)
suppressed sensitization and induced Treg similar to UVR. Here we show that antigen-presenting cells are
critically involved in AhR-induced immunosuppression. Injection of hapten-coupled dendritic cells (DCs) treated
with NP into mice did not result in sensitization but induced Treg. NP induced the release of IL-2 by DC that
subsequently triggered the release of IL-10. NP upregulated the negative regulatory molecule B7-H4 via the
release of IL-2 that was functionally relevant as inhibition of B7-H4 prevented the induction of Treg. Together, this
indicates that activation of the AhR switches antigen-presenting cells from a stimulatory into a regulatory
phenotype, ultimately inducing Treg. Thus, AhR agonists may represent an alternative to suppress the immune
system like UVR but without causing the adverse effects of UVR including DNA damage.
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INTRODUCTION
UVR has been identified to suppress the immune system in an
antigen-specific manner via induction of regulatory T cells
(Tregs) (Schwarz and Beissert, 2013). Because of their antigen
specificity, UVR-induced Treg (UVR-Treg) may harbor
therapeutic potential and may be superior to immuno-
suppressive drugs that suppress the immune system in a
general manner and thus cause severe side-effects (Beissert
et al., 2006). However, induction of DNA damage by UVR
(cyclobutane pyrimidine dimers,o6–44 photoproducts) is an
essential molecular event required for the generation of UVR-
Treg (Schwarz et al., 2005). In order to avoid DNA damage,
which is the major basis for skin cancer (Nindl and Rosl,
2009), strategies are sought that induce Treg with similar
features but without causing DNA damage.
We recently observed that activation of the aryl hydrocar-
bon receptor (AhR) induces Tregs that at the current status
appear to be identical or at least closely related to UVR-Treg
(Navid et al., 2013). The AhR is a widely expressed
ligand-triggered transcription factor mostly responsible for
the detoxification of aromatic hydrocarbons (Abel and
Haarmann-Stemmann, 2010). The AhR, however, seems to
be involved also in other cellular processes including cell
growth, proliferation, differentiation, and apoptosis, as well as
skin inflammation and pigmentation. The AhR was found to
be activated by UVR and thus identified as a further molecular
target for UVR (Fritsche et al., 2007). Accordingly, it was
shown that activation of the AhR by UVR is involved in UVR-
mediated immunosuppression as induction of UVR-Treg could
be prevented by AhR antagonists (Navid et al., 2013). This
observation inspired the assumption that activating AhR
ligands might be a suitable tool to induce Treg in a UVR-
independent manner. Accordingly, the AhR agonist 4-n-
nonylphenol (NP) inhibited the induction of contact
hypersensitivity (CHS) and induced Treg that acted in a
similar manner as UVR-Treg (Navid et al., 2013). The
current characterization of AhR-induced Treg (AhR-Treg) did
not show any differences to UVR-Treg so far, although the
comparative phenotypic and functional characterization is not
yet complete. Nevertheless, we might have identified with NP
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a substance that induces antigen-specific Treg similar to UVR
but without causing DNA damage. Hence, we are interested
in further characterizing AhR-Treg functionally and pheno-
typically and to identify the molecular mechanisms by which
AhR ligands induce Treg. Here we show that this effect is
achieved primarily by modulation of antigen-presenting cells .
NP appears to shift dendritic cells (DCs) from a stimulatory
into a regulatory phenotype that ultimately results in the
generation of Treg.
RESULTS
Immunosuppression by NP-treated DC is AhR dependent
Injection of the AhR agonist NP into mice was shown to
induce Tregs that suppress immune responses in an antigen-
specific manner (Navid et al., 2013). We already surmised that
NP might induce Treg by modulating antigen-presenting cells
as subcutaneous (s.c.) injection of trinitrochlorobenzoesul-
fonic acid (TNBS)–coupled bone marrow–derived dendritic
cells (BMDCs) did not induce CHS against trinitrochloroben-
zene (TNCB) when the BMDCs were exposed to NP before
injection (Navid et al., 2013). In addition, injection of
NP-exposed BMDCs induced Treg as demonstrated by
adoptive transfer experiments (Navid et al., 2013). To prove
whether NP exerts this effect via activation of the AhR
(Bonefeld-Jrgensen et al., 2007), AhR knock-out (AhR-KO)
mice were used.
Intraperitoneally injected NP (100ml 600 nM) induced the
expression of the AhR-controlled enzyme CYP1A1 in lymph
nodes as demonstrated by quantitative real-time PCR
(Figure 1a). This was not observed in AhR-KO mice, indicating
that the NP dose injected activates the AhR in vivo. BMDCs
obtained from wild type (WT) or AhR-KO mice were cultured
with or without NP (600 nM). On day 8, BMDCs were coupled
with TNBS, washed, and 7105 cells were injected s.c. into
naive mice. Challenge with TNCB was performed 5 days later.
Mice that received TNBS-coupled BMDCs from WT mice
responded with a pronounced ear swelling upon challenge
with TNCB (Figure 1b; WT, #1). In contrast, recipients of
TNCB-coupled BMDCs cultured with NP revealed a signifi-
cantly reduced ear swelling response (#2), confirming pre-
vious results (Navid et al., 2013). Recipients that received
BMDCs from AhR-KO mice were not suppressed in their CHS
response independently of NP treatment (Figure 1b; AhR-KO,
#1, #2). This indicates that the alteration of the antigen-
presenting potency of BMDCs by NP is AhR dependent and
excludes the possibility that NP exerts this effect via other
mechanisms.
The same applies for the induction of Treg by NP-modified
BMDCs. As shown previously (Navid et al., 2013), injection of
lymph node cells and splenocytes obtained from mice that
were injected with NP-treated BMDCs suppressed the
induction of CHS in recipients (Figure 1c, WT, #4). In contrast,
recipients of cells from donors that were injected with
NP-treated BMDCs obtained from AhR-KO mice revealed a
similar ear swelling response (Figure 1c, AhR-KO, #4) as
recipients receiving cells from donors that were injected with
BMDCs just coupled with TNBS but not exposed to NP
(Figure 1c, AhR-KO, #3).
Being a key transcription factor in the development of
natural CD4þCD25þ T cells, Foxp3 is currently regarded as
one of the most specific markers for Treg (Ramsdell and
Ziegler, 2014). To clarify whether Treg induced by NP-
modified BMDCs express Foxp3, we utilized DEREG mice
(DEpletion of REGulatory T cells). These mice express a
diphtheria toxin receptor–enhanced green fluorescent protein
GFP under control of the foxp3 gene locus (Lahl et al., 2007).
Injection of diphtheria toxin results in the depletion of Foxp3-
positive cells. BMDCs obtained from WT mice were cultured
with NP, on day 8 coupled with TNBS, washed, and injected
s.c. into DEREG mice. After another 48 hours, 1mg diphtheria
toxin per mouse was injected i.p. for 3 consecutive days. Five
days after injection of BMDCs, lymph node cells and
splenocytes were obtained and injected into naive WT mice.
Twenty-four hours later, the recipients were sensitized against
TNCB and ear challenge was performed 5 days thereafter. Cells
obtained from DEREG donors injected with NP-treated BMDCs
significantly suppressed CHS in the recipients (Figure 1d, #3). In
contrast, sensitization was not reduced upon transfer of cells
obtained from DEREG mice injected with NP-treated BMDCs
and treated with diphtheria toxin (Figure 1d, #4). This indicates
that NP-treated BMDCs induce Tregs that express Foxp3.
IL-2 is critically involved in NP-mediated induction of Treg
by DC
Recently, it was shown that IL-2 released from DC is crucially
involved in the development of Treg (Kulhankova et al., 2012;
Zelante et al., 2012). To analyze whether NP induces IL-2 and
thus supports the development of Treg, antibodies neutralizing
IL-2 were used. BMDCs were cultured in the absence or
presence of NP. To one group a neutralizing anti-IL-2 antibody
was added 24 hours before cells were coupled with TNBS.
Cells were injected s.c. into naive mice, and challenge with
TNCB was performed 5 days later. Mice injected with TNBS-
coupled BMDCs responded with pronounced ear swelling
(Figure 2a, #1). In contrast, the CHS response in the recipients
injected with BMDCs cultured with NP was significantly
reduced (#3). The immunosuppressive effect of NP was
abolished upon addition of the neutralizing anti-IL-2 antibody
(#4). To study whether Treg development is impaired upon
blocking IL-2, adoptive transfer experiments were performed.
Lymph node cells and splenocytes obtained from respective
donors (Figure 2a, #1, #3, #4) were injected into naive mice.
Recipients were sensitized 24 hours later. Recipients of cells
obtained from mice injected with NP-treated BMDCs were
significantly suppressed in their ear swelling response
(Figure 2b, #4). In contrast, recipients of cells from donors
injected with untreated BMDCs responded with a pronounced
CHS reaction (#3). Sensitization was not at all suppressed in
mice receiving cells from donors that were injected with
NP- and anti-IL-2-treated BMDCs (#5). These results imply that
IL-2 released by DC is essentially involved in NP-mediated
immunosuppression and induction of Treg.
Activation of the AhR in BMDCs alters cytokine secretion
Beside IL-2, which was shown to be essentially involved in
NP-mediated induction of Treg (Figure 2), IL-10 and
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transforming growth factor-b (TGF-b) are involved in immu-
nosuppression and the induction of Treg (Steinbrink et al.,
1997; Lan et al., 2006). Thus, the effect of NP on the release of
these cytokines was analyzed. BMDCs cultured for 8 days in
the presence or absence of NP were stimulated with
lipopolysaccharide for additional 48 hours and supernatants
analyzed by ELISA. Stimulation with NP increased the
release of IL-2, IL-10, and TGF-b (Figure 3a), whereas the
secretion of IL-6, TNF-a, and IFN-g was not affected (data
not shown). Addition of an anti-IL-2-antibody during the
culture period prevented the NP-induced release of IL-10
(Figure 3b).
NP induces indoleamine 2,3-dioxygenase (IDO) and alters the
expression of costimulatory molecules on DC
Activation of IDO in DC can suppress T-cell proliferation.
IDO catalyzes tryptophan degradation, finally resulting in
deficiency of tryptophan, which is a crucial proliferative
stimulus for effector T cells (Harden and Egilmez, 2012).
A tryptophan-deprived environment drives effector T cells into
apoptosis. RNA was extracted from BMDCs exposed to NP,
and quantitative real-time PCR for IDO was performed. NP
remarkably induced IDO expression (Figure 3c). This appears
to be functionally relevant as preliminary data revealed
enhanced levels of kynurenin, the degradation product of
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Figure 1. Immunosuppression by 4-n-nonylphenol (NP)-treated dendritic cell (DC) is aryl hydrocarbon receptor (AhR) dependent. (a) Wild-type (WT) mice were
injected intraperitoneally with 100ml of 600 nM NP for 4 consecutive days. Forty-eight hours after the last injection, lymphocytes and splenocytes were dissected
and RNA was isolated. After DNaseI digestion and reverse transcription, the complementary DNA was subjected to quantitative real-time PCR and mRNA
expression of cyp1a1 was measured. Relative expression of cyp1a1 was normalized to the expression of the housekeeping gene b-actin. (b) Bone marrow–derived
dendritic cell(s) (BMDCs) of WT or AhR-KO mice were incubated in the absence (#1) or presence of 600 nM NP (#2). After 8 days, BMDCs were pulsed with
trinitrochlorobenzoesulfonic acid (TNBS) and injected subcutaneously (s.c.) into naive WT mice. After 5 days, ear challenge against trinitrochlorobenzene (TNCB)
was performed, and 24 hours later ear swelling was measured. Negative control (Neg Co) mice were only challenged. Bars show mean±SD of increase in ear
thickness expressed as the difference between the thicknesses of the challenged ear compared with the vehicle-treated ear. *Po10 3 versus BMDC. (c) Lymph
node cells and splenocytes obtained from mice that were injected with untreated (#3) or NP-treated (#4) BMDCs obtained either from WT or AhR-KO mice were
injected intravenously (5 107 per mouse) into naive mice (Transfer). Twenty-four hours later, recipients were sensitized against TNCB, and 5 days later ears were
challenged. *Po103 versus positive control (Pos Co); **Po104 versus BMDCs (d) BMDCs from WT mice were cultured in the absence or presence of for 8
days coupled with TNBS and injected s.c. into DEpletion of REGulatory T cells mice. Forty-eight hours after injection, one group of recipients was injected with
1mg diphtheria toxin (DT) for 3 consecutive days. Five days after BMDC injection, lymph node cells and splenocytes were obtained and injected into naive WT
mice that were sensitized against TNCB 24 hours. *Po0.01 versus Pos Co; **Po104 versus DT.
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Figure 3. Activation of the aryl hydrocarbon receptor in bone marrow–derived dendritic cells (BMDCs) alters cytokine secretion. (a) BMDCs were incubated
with or without 4-n-nonylphenol (NP) for 8 days. Supernatants were collected and cytokines measured by ELISA. *Po0.05 versus BMDC; **Po0.01 versus BMDC
(b) BMDCs were incubated without NP (#1), with NP (#2), or with NP and a neutralizing anti-mouse IL-2 antibody (#3). IL-10 levels in the supernatants were
measured by ELISA. *Po105 versus BMDC; **Po105 versus BMDCþNP. (c) BMDCs were incubated in the absence or presence of NP. After 8 days, RNA
was isolated. Reverse transcribed complementary DNA was subjected to quantitative real-time PCR and mRNA expression of indoleamine 2,3-dioxygenase (IDO)
measured. Relative expression of IDO was normalized to the expression of the housekeeping gene b-actin. *Po0.05.
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Figure 2. IL-2 is critically involved in 4-n-nonylphenol (NP)-mediated induction of Treg. (a) Bone marrow–derived dendritic cells were incubated without NP
(#1), with NP (#3), or with NP and an anti-mouse IL-2 antibody (#4). After trinitrochlorobenzoesulfonic acid pulsing cells were injected subcutaneously into naive
mice. Five days later, ears were challenged with trinitrochlorobenzene (TNCB) and ear swelling measured 24 hours later. *Po10 6 versus positive control
(Pos Co); **Po10 5 versus NP (b) lymph node cells and splenocytes were obtained from mice (Figures 2a, #1, #3, #4) and injected intravenous into naive mice.
Twenty-four hours after transfer, recipients were sensitized with TNCB. Five days later, ears were challenged and ear swelling was measured after 24 hours.
*Po0.05 versus no NP; **Po105 versus NP.
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tryptophan, in the supernatants of NP-treated BMDCs. The
inhibition of T effector cells was also confirmed in allostimu-
latory coculture experiments. Incubation of C57BL/6 BMDC
with Balb/c T cells induced the secretion of IL-2 and IFN-y,
which was significantly reduced upon incubation of BMDCs
with NP (data not shown).
Expression of costimulatory molecules such as major histo-
compatibility complex (MHC) class II, B7-2, B7-H1, B7-H3,
and B7-H4 determines the activation and maturational status
of DC (Jung and Choi, 2013). B7-H1, B7-H3, and B7-H4
exhibit inhibitory function for antigen presentation, whereas
MHC class II and B7-2 are required for the induction of
immune responses. The obvious question whether NP alters
the expression of costimulatory molecules on DC was
addressed by FACS analysis. BMDCs cultured in the absence
or presence of NP were stained with specific antibodies
directed against MHC class II, B7-2, B7-H1, B7-H3, and B7-
H4, respectively, and subjected to FACS analysis. NP reduced
the expression of B7-2 and MHC class II slightly. Expression of
B7-H3 and B7-H4 was significantly upregulated by NP,
whereas B7-H1 was not altered (Figure 4). The induction of
B7-H3 and B7-H4 by NP appears to be mediated via IL-2, as
addition of an anti-IL-2-antibody reduced the enhanced
expression (Figure 5).
Expression of B7-H4 is functionally relevant for NP-mediated
immunosuppression and the induction of Treg
To clarify whether the expression of B7-H4 is functionally
relevant, an anti-B7-H4 antibody was used. BMDCs were
cultured in the absence or presence of NP as described above.
To one group of NP-treated BMDCs the blocking anti-B7-H4
antibody (10mg ml1) was added. Twenty-four hours later,
cells were labeled with TNBS and injected s.c. into naive
mice. Challenge with TNCB was carried out 5 days later.
Although the ear swelling response was significantly reduced
in recipients of NP-treated BMDCs, the ear swelling response
of mice that had received NP-treated BMDCs, which had been
in addition treated with the antibody, was almost as pro-
nounced as that of positive control mice that had been
injected with TNBS-coupled BMDCs (Figure 6a). Adoptive
transfer experiments with cells obtained from the mice
displayed in Figure 6a revealed suppression of the induction
of CHS in recipients of cells of donors that were injected with
NP-treated BMDCs (Figure 6b). This suppression was not
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Figure 4. 4-n-nonylphenol (NP) alters the expression of costimulatory molecules on dendritic cells. Bone marrow–derived dendritic cells were either left
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observed upon transfer of cells from donors that received
BMDCs, which in addition to NP were treated with the
antibody, implying that in the presence of the B7-H4 antibody
Treg did not develop.
To determine whether B7-H4 has the same crucial role in
immunosuppression induced by direct injection of NP into
mice, mice were injected intraperitoneally (i.p.) with NP for
4 days and sensitized with TNCB. One group was additionally
injected with the anti-B7-H4 antibody (100mg per mouse)
3 hours before sensitization. Induction of CHS and adoptive
transfer experiments were performed as described above.
Comparable to the data when using BMDCs, mice that were
injected with NP and the B7-H4 antibody revealed a pro-
nounced CHS reaction (Figure 6c, #4), in contrast to NP-
injected mice whose ear swelling was significantly suppressed
(Figure 6c, #3). Transfer experiments indicated that injection
of NP induced Treg. The development of Treg, however, was
prevented when B7-H4 was blocked in the donors by the
antibody (Figure 6d).
DISCUSSION
This study expands on our previous observation that activation
of the AhR by the agonist NP prevents sensitization and
induces Treg comparable with UVR (Navid et al., 2013). In
line with previous reports (Jin et al., 2010; Quintana et al.,
2010), we already provided preliminary evidence that NP
suppresses the immune system by primarily acting on DC, as
s.c. injection of hapten-coupled BMDCs, which were treated
with NP, lost the capacity to induce sensitization but in turn
induced Treg. These findings were confirmed in the present
work. In addition, we show that NP exerts this effect via
activation of the AhR as it was not observed with BMDCs
obtained from AhR-KO mice.
Accordingly, intraperitoneally injected NP induced in
lymph nodes the mRNA expression of CYP1A1, an enzyme
that is controlled by the AhR. These experiments exclude the
possibility that NP exerts its immunosuppressive effects by
utilizing other signaling pathways beyond the AhR. This is
important to mention as NP has been reported to exert xeno-
estrogenic effects but only at rather high concentrations above
0.5 mg kg1 (Watanabe et al., 2004). As we injected
0.66 10 3 mg kg 1 it is highly unlikely that the immuno-
suppressive effects caused by NP are mediated via xeno-
estrogenic effects.
We also selected such low concentrations for our experi-
ments to make sure to avoid genotoxic effects. These have
been detected with different methods (sister chromatid
exchange, chromosome aberration, comet assays) but only
at concentrations that were in a 170- to 10,000-fold higher
range (Harre´us et al., 2002; Grisolia et al., 2004; Tayama
et al., 2008) than which we utilized for our experiments. NP is
rapidly absorbed, metabolized by CYP2B and CYP3B, and
eliminated within 24 hours of exposure (Green et al., 2003)
via glucoronidation by a UDP-glucuronosyltransferase and
excreted (Daidoji et al., 2003).
Recently, it was shown that AhR signaling is not only
activated by compounds that bind to the AhR but also by
substances that inhibit CYP1A1 enzyme activity. Disturbance
of CYP1A1 activity may lead to metabolic stabilization of
putative endogenous AhR ligands (e.g., 6-formylindolo[3,2b]-
carbazole, a tryptophan photoproduct) and subsequent activa-
tion of AhR signaling (Wincent et al., 2012). To test whether
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NP is a CYP1A1 inhibitor and thus an indirect activator of
AhR, we analyzed the effect of NP on benzo(a)pyrene-induced
7-O-ethoxyresorufin deethylation (EROD) as an established
indicator reaction for CYP1A1 activity. In contrast to the
specific CYP1A1 inhibitor 7-hydroxyflavone (Zhai et al.,
1998) NP did not suppress EROD activity (data not shown).
This indicates that NP at the concentrations used in this study
does not act as a CYP1A1 inhibitor but rather directly activates
the AhR, which is in line with the above-mentioned PCR and
AhR-KO data.
Accordingly, AhR-KO mice turned out to be resistant to
UVR-induced immunosuppression (Navid et al., 2013), indica-
ting that activation of the AhR by UVR might be a crucial event
in UVR-induced immunosuppression, although certainly being
not the only signaling pathway involved. NP-treated DC
induced Treg that express Foxp3, as demonstrated in DEREG
mice. Thus, we surmise that NP induces Treg that behave
functionally and phenotypically in a similar manner as UVR-
Treg. However, we have to admit that the studies comparing
UVR-Treg and NP-Treg have not yet been completed.
Activation of the AhR by NP triggers the release of IL-2 by
DC. Although it is known for quite a while that IL-2 induces
the expression of Foxp3 and is essential for maintaining Treg
(Turka and Walsh, 2008), it has only recently been recognized
that DCs by themselves produce IL-2 and thereby induce and
expand, respectively, Treg in a juxtacrine manner (Kulhankova
et al., 2012; Zelante et al., 2012). IL-2 release by DC upon
AhR activation appears to be a crucial event in immuno-
suppression, as addition of an anti-IL-2 antibody to the culture
completely prevented the inhibition of sensitization and the
induction of Treg.
IL-10 and TGF-b are additional cytokines involved in
shifting DC into a tolerogenic phenotype and inducing Treg
(Kretschmer et al., 2005). DCs stimulated to produce TGF-b
support the differentiation and expansion of Treg (Ghiringhelli
et al., 2005a, b; Kushwah and Hu, 2011). IL-10 when added
to maturing DC induces semi-mature DCs, which induce Treg
(Steinbrink et al., 1997; McBride et al., 2002; Lan et al., 2006).
However, DCs are also able to secrete IL-10. DCs propagated
in IL-10 and TGF-b and stimulated with lipopolysaccharide
were found to express low levels of surface MHC class II,
CD40, CD80, and B7-2, secreted high levels of IL-10, and
expanded Foxp3þ Treg with enhanced suppressive activity
(Lan et al., 2006). Hence, it was obvious to test whether
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Figure 6. Expression of B7-H4 is functionally relevant for 4-n-nonylphenol (NP)-mediated immunosuppression and induction of Treg. (a) Bone marrow–derived
dendritic cells were incubated without NP (#1), with NP (#3), or with NP and an anti-B7-H4 antibody (#4). After trinitrochlorobenzoesulfonic acid pulsing, cells
were injected subcutaneously into naive mice. Five days later, ears were challenged with trinitrochlorobenzene (TNCB) and ear swelling measured 24 hours later.
*Po0.005 versus no NP; **Po0.01 versus NP. (b) Lymph node cells and splenocytes were obtained from mice (a, #1, #3, #4) and transferred intravenously (i.v.)
into naive mice. Recipients were sensitized 24 hours after injection, and ear challenge was performed 5 days thereafter. *Po0.05 versus no NP; **Po106 versus
NP. (c) Mice were injected intraperitoneally with NP (200ml of 600 nM) for 4 consecutive days (#3, #4) and an anti-B7-H4 antibody (#4) 3 hours before
sensitization. Five days later ears were challenged with TNCB and ear swelling measured 24 hours later. *Po0.05 versus positive control (Pos Co); **Po0.005
versus NP. (d) Lymph node cells and splenocytes were obtained from NP-injected mice (c, #3, #4) and transferred i.v. into naive mice. Twenty-four hours after
injection, recipients were sensitized and challenge was performed 5 days later. *Po106 versus Pos Co; **Po105 versus NP.
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NP-treated DCs release TGF-b and IL-10. Both cytokines were
found to be released at increased levels upon stimulation with
NP. However, the increase was rather moderate and it is not
yet clear, whether the release of these two cytokines is
functionally relevant as we have not yet performed blocking
studies utilizing neutralizing antibodies. However, the release
at least of IL-10 appears to be mediated via IL-2, as
neutralization of IL-2 by a blocking antibody prevented the
enhanced secretion of IL-10. This implies that IL-2 might be a
master switch controlling the induction of Treg.
The same appears to apply for costimulatory molecules that
determine the outcome of an immune response (Jung and
Choi, 2013). Alteration of the expression of costimulatory
molecules by AhR ligands has been already described.
Vorderstrasse et al., (2003) observed modulation of the
expression of MHC class II, CD24, ICAM-1, CD40, and
LFA-1 on splenic DC by 2,3,7,8-tetrachlorodibenzo-p-
dioxine, the classical AhR ligand. NP downregulated the
expression of MHC class II and B7-2 molecules slightly.
Most importantly, NP induced the expression of the negative
regulatory molecules B7-H3 and B7-H4. This again appears to
be at least partially mediated via IL-2, as addition of an anti-
IL-2 antibody reduced the induction. Several studies
demonstrated that upregulation of B7-H3 and B7-H4 on DC
leads to an impaired T-cell stimulatory function (Kryczek
et al., 2006; Mahnke et al., 2007). In these studies upregu-
lation of B7-H3 and B7-H4 was mediated by IL-10. In our
hands, blocking of IL-10 both in vitro and in vivo did not
abolish the NP-mediated effects (data not shown), suggesting
that NP exerts this effect independently of IL-10. Nevertheless,
expression of B7-H4 appears to be functionally relevant, as
inhibition of B7-H4 by an antibody prevented the suppression
of sensitization and the induction of Treg. It is important to
notice that this was observed when DCs were treated with an
anti-B7-H4 antibody and then injected into naive mice for
sensitization, but also when NP was directly injected into
mice in combination with the anti-B7-H4 antibody.
However, modulation of accessory molecules may not be
the only mode of action by which NP switches DC from a
stimulatory into a regulatory phenotype. Incubation of BMDCs
induced the expression of IDO. IDO depletes tryptophan,
which is crucial for T-cell proliferation. This is in line with
studies utilizing AhR-KO, indicating that the AhR is required
for IDO expression (Nguyen et al., 2010). Accordingly,
allogeneic T-cell stimulation was inhibited when DCs were
pretreated with NP.
Together, these data imply that activation of the AhR
switches DC from a stimulatory into a regulatory phenotype
that finally supports the generation of Treg. Secretion of IL-2
may be a master switch in this process, and the expression of
B7-H4 appears to be required for the induction of Treg.
Although being differently induced AhR-Treg appear to exert
the same activities as UVR-Treg. Thus, certain types of AhR
ligands may represent a suitable alternative to modulate the
immune system in a similar antigen-specific manner like UVR
with the advantage of inducing antigen-specific and not
general immunosuppression but without causing the adverse
effects of UVR including DNA damage.
MATERIALS AND METHODS
Animals
Seven- to eight-week-old female C57BL/6J mice were purchased from
Charles River Laboratories (Sulzfeld, Germany). AhR-KO mice were
provided by J. Krutmann (Schmidt et al., 1996). Mice were bred in the
central animal facilities of the University Clinics Schleswig-Holstein.
Animal care was utilized by expert personnel under specific
pathogen-free conditions in compliance with relevant laws and
institutional guidelines.
Reagents
As an AhR agonist NP, (Sigma-Aldrich, Taufkirchen, Germany) was
used. For neutralizing IL-2 activity purified anti-mouse IL-2 (JES6-
1A12; BioLegend, San Diego, CA) was used in a concentration of
5mg ml 1. For neutralizing B7-H4 activity in vitro purified anti-
mouse B7-H4 (HMH4-5G1; BioLegend) was used in a concentration
of 10mg ml 1. For in vivo experiments 100mg per mouse was
injected i.p.
Quantitative real-time PCR
RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden,
Germany), treated with DNaseI, and converted to complementary
DNA by reverse transcription. Quantitative detection of cyp1a1, ido,
and -actin was performed with the StepOnePlus system (Applied
Biosystems by Life Technologies, Darmstadt, Germany) using a SYBR
Green Master Mix (Life Technologies) according to the manufacturer’s
instructions. Oligonucleotide sequences were as follows: cyp1a1
forward: 50-ATATCCCCAAGGGGTGCTGT-30; cyp1a1 reverse: 50-TT
CAGGCCGGAACTCGTTTG-30; ido forward: 50-GGCTTCTTCCTCG
TCTCTCTATTG-30; ido reverse: 50-TGACGCTCTACTGCACTGGA
TAC-30 -actin forward: 50-CCCTGAGGAGCACCCTGT-30; -actin
reverse: 50-GTACATGGCTGGGGTGTTGA-30. Relative gene expres-
sion was normalized to b-actin according to the delta delta cycle
threshold method (Livak and Schmittgen, 2001).
Flow cytometric analysis
For analysis of the expression of MHC class II, a phycoerythrin-
labeled rat anti-mouse I-A/I-E antibody (BD, Heidelberg, Germany)
was used. For determination of the expression of B7-2, B7-H1,
B7-H3, and B7-H4 the following antibodies were used: allophyco-
cyanine-conjugated anti-mouse B7-2 (Beckman Coulter, Krefeld,
Germany) and phycoerythrin-labeled anti-mouse antibodies against
B7-H1, B7-H3, and B7-H4 (eBioscience, San Diego, CA). Protein
expression was analyzed by flow cytometry (FC500; Beckman
Coulter).
Contact hypersensitivity
Mice were sensitized by painting 50ml TNCB solution (1.0% in
acetone:olive oil, 4:1) on the shaved back. After 5 days, challenge
was performed with 20ml 0.5% TNCB on the left ear. Twenty-four
hours later, the ear swelling response was measured with a spring-
loaded micrometer and determined as the amount of the hapten-
treated ear compared with vehicle-treated ear and expressed in cm 3
(mean±SD).
Generation of BMDCs
BMDCs were generated by culture of bone marrow cells obtained
from tibias (Schwarz and Schwarz, 2010). For sensitization via
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injection with hapten-labeled antigen-presenting cells, BMDCs were
labeled with 1 mM TNBS, the water-soluble derivative of TNCB, for
30 minutes at 37 1C. After washing, 7 105 cells were injected s.c.
into naive mice. After 5 days, ear challenge with TNCB was
performed and ear swelling measured 24 hours later.
Cytokine measurement
Cytokines were assayed by conventional sandwich ELISA using 96-
well plates coated with antibody specific for the respective antibody
according to the manufacturer’s protocol (BioLegend).
EROD activtiy
For determination of EROD activity, 3 104 PAM 212 cells were
seeded into 48-well plates and cultured for 24 hours. EROD activity
was induced by a 24 hours exposure to 1mM benzo(a)pyrene, and
control cells were treated with DMSO. In order to test the inhibitory
capacity of NP on CYP1A1 activity, benzo(a)pyrene-treated cells
were co-exposed to 600 nM NP for 30 minutes before measurement of
enzyme kinetics. As positive control, benzo(a)pyrene-treated cells
were co-exposed for 30 minutes to 600 nM of the specific CYP1A1
enzyme inhibitor 7-hydroxyflavone. The final DMSO concentration
in all samples was adjusted to 0.2%. Subsequently, cells were
incubated with 2.5mM 7-ethoxyresorufin in serum-free medium
containing 10mM dicumarol. EROD activity was monitored in a
Tecan Infinite F200 plate reader (Tecan, Ma¨nnedorf, Switzerland) at
544 nm excitation and 590 nm emission. Resorufin increase was
monitored for 30 minutes and quantified using a resorufin standard
curve. After measurement, cells were washed with phosphate-
buffered saline and protein content was determined using the CBQCA
kit (Molecular Probes, Leiden, The Netherlands). Fluorescence was
measured at 485 nm excitation and 538 nm emission. Enzyme
activities are shown as pmol minute 1 per mg protein (Tigges
et al., 2013).
Statistical analysis
Statistical analysis was performed using one-way analysis of variance
for multiple and Student’s t-test for pairwise comparisons. Differences
between the means and±SD with Po0.05 were considered statisti-
cally significant. In case of multiple group comparisons P-values from
post hoc tests with the corresponding control group were Bonferroni
corrected. Unless otherwise stated, data show one representative of
three independently performed experiments with at least six mice per
group.
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